Radioisotope
I-131
Diagnostics and thyroid gland treatment: for an
evaluation of thyroid gland function, scanning and
scintigraphy of thyroid gland at various diseases,
including for diagnostics of infringement of thyroid
gland functions, and also small-celled cancer of a
thyroid gland and metastasises.
Sm-153
Used in oncology with the aim of a persistent
reduction in the intensity of the pain syndrome,
caused by the presence of metastatic damage bones and for rheumatic patients with severe pain
syndrome.
Lu-177
Treatment of neuroendocrine tumors with
metastases. The drug is intended for IV injections.
The patient is also treated with a protective drug to
reduce the radiation exposure. The drug has a potent effect in destroying the cancer cells. In some cases, a full recovery occurs, but Lu-177 is mainly used to
relieve clinical manifestations of cancer disease.
Y90
This radiopharmaceutical radiation therapy which
focuses high doses of radiation on the tumor and
minimize damage to healthy tissues around the liver. It is also suitable for hepatocellular carcinomas with portal vein invasion
I131-MIBG
This radiopharmaceutical is also effective in reducing the symptoms of neuroendocrine tumors, including
carcinoid tumors and medullary thyroid carcinoma.